STOCK TITAN

Inmed Pharmaceuticals Inc (INM) Total Assets by Year

INM

Inmed Pharmaceuticals Inc closed fiscal year 2025 with $15.6M in total assets, $2.1M in total liabilities and $13.4M in shareholder equity. This represents an increase of 31.8% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Inmed Pharmaceuticals Inc has filed alongside them.

FY2025 annual
Total Assets $15.6M
Total Liabilities $2.1M
Total Equity $13.4M
YoY +31.8%
5Y CAGR +14.8%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INM Balance Sheet by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25S-4FY24S-4FY2310-KFY2210-KFY2110-KFY2010-K
Total Assets$15.6M+31.8%$11.8M-16.2%$14.1M+10.3%$12.8M+30.7%$9.8M+25.4%$7.8M
Total Liabilities$2.1M-18.0%$2.6M+29.8%$2.0M-45.6%$3.7M+54.2%$2.4M+25.0%$1.9M
Total Equity$13.4M+45.9%$9.2M-23.9%$12.1M+33.2%$9.1M+23.1%$7.4M+25.5%$5.9M

INM Balance Sheet by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'26S-4Q2'2610-QQ1'2610-QQ4'25S-4Q3'2510-QQ2'2510-QQ1'2510-QQ4'24S-4Q3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Total Assets$9.1M-1.6%$11.2M+31.6%$13.4M+27.7%$15.6M+31.8%$9.3M$8.5M-44.3%$10.5M-4.1%$11.8M-16.2%N/A$15.3M-9.8%$10.9M-25.1%$14.1M+10.3%
Total Liabilities$2.2M-0.7%$1.6M-30.9%$1.8M-14.5%$2.1M-18.0%$2.3M$2.3M-6.6%$2.1M-89.9%$2.6M+29.8%N/A$2.5M-3.9%$20.5M+473.1%$2.0M-45.6%
Total Equity$6.9M-1.8%$9.6M+55.1%$11.6M+38.1%$13.4M+45.9%$7.0M-36.8%$6.2M-51.6%$8.4M+187.7%$9.2M-23.9%$11.1M-10.4%$12.8M-10.9%-$9.6M-187.0%$12.1M+33.2%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Inmed Pharmaceuticals Inc financials

Frequently Asked Questions

What was Inmed Pharmaceuticals Inc's total assets in fiscal year 2025?

Inmed Pharmaceuticals Inc closed fiscal year 2025 with $15.6M in total assets, $2.1M in total liabilities and $13.4M in shareholder equity.

How fast is Inmed Pharmaceuticals Inc's total assets growing?

Inmed Pharmaceuticals Inc (INM) total assets rose by 31.8% year over year, from $11.8M to $15.6M in fiscal year 2025.

How has Inmed Pharmaceuticals Inc's total assets changed over the years?

Across the 6 fiscal years this page covers, Inmed Pharmaceuticals Inc (INM) total assets went from $7.8M in fiscal year 2020 to $15.6M in fiscal year 2025.

Inmed Pharmaceuticals Inc (INM) reported $9.1M in total assets in Q3 2026. This represents a decrease of 1.6% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Inmed Pharmaceuticals Inc (INM) reported on that line in every period on record.